Insider Transactions Reported by 18 Insiders of Skye Bioscience, Inc.

Symbol
SKYE on Nasdaq
Location
San Diego, CA

Insiders trading volume in the past year

Skye Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Andrew J. Schwab Director, 10%+ Owner $33,439,506 -$800,549 -2.3% 21 Aug 2025
5AM Partners VII, LLC 10%+ Owner $33,438,316 -$800,549 -2.3% 21 Aug 2025
Versant Ventures III, LLC 10%+ Owner $9,386,012 18 Aug 2023
Emerald Health Sciences Inc. 10%+ Owner $3,167,928 10 Nov 2022
PUNIT DHILLON Chief Executive Officer, Director $1,703,489 24 Feb 2025
Paul A. Grayson Director $1,297,098 24 Feb 2025
Kaitlyn Arsenault Chief Financial Officer $838,060 24 Feb 2025
Tuan Tu Diep Chief Development Officer $412,597 24 Feb 2025
Christopher Twitty Chief Scientific Officer $147,251 23 Apr 2025
Sukhwinder Singh Rai Director $6,040 05 Jan 2023
Puneet S. Arora Chief Medical Officer $3,825 24 Feb 2025
Karen L. Smith Director $1,190 24 Feb 2025
Annalisa Jenkins Director $1,190 24 Feb 2025
Deborah H. Charych Director $1,190 24 Feb 2025
Keith Wayne Ward Director $595 29 Feb 2024
PRAVEEN TYLE Director $595 29 Feb 2024
MARGARET DALESANDRO Director $595 29 Feb 2024
James L. Heppell Director 14 Sep 2021

Recent Insider Transactions by Companies or Individuals for Skye Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.